About Contact Us Careers

Immunotherapy Drugs Market Share

Request Free Sample Copy

Report ID: 60
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Buy Now

Immunotherapy Drugs Market Share

North America Market Statistics

On the basis of regional analysis, the global immunotherapy drugs market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa regions. North America industry is predicted to account for largest revenue share by 2037, on the back of presence of several key players, along with growing number of new cancer cases registered every year in the region.

Immunotherapy Drugs Market Share Segmentation by Therapy Area

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Immunotherapy Drugs Market Size & Share, Growth Trends 2037 [2025 Updated]

Author Credits: Radhika Pawar

Report ID: 60
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of immunotherapy drugs is estimated at USD 327.72 billion.

Immunotherapy Drugs Market size was valued at USD 290.22 billion in 2024 and is set to exceed USD 1.82 trillion by 2037, registering over 15.2% CAGR during the forecast period i.e., between 2025-2037.

North America industry is predicted to account for largest revenue share by 2037, on the back of presence of several key players, along with growing number of new cancer cases registered every year in the region.

The major players in the market are Merck & Co., Inc., Gilead Sciences, Inc., Pfizer Inc., AstraZeneca PLC, Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, and others.

Inquiry Before Buying Request Free Sample